These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37140428)

  • 1. Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity
    Li A; He S; Li J; Zhang Z; Li B; Chu H
    Microbiol Spectr; 2023 Jun; 11(3):e0071823. PubMed ID: 37140428
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kaushik A; Ammerman NC; Martins O; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962331
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0068922. PubMed ID: 35943269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative
    Mirza HC; Güçlü AÜ; İnce Ceviz G; Başustaoğlu A
    J Med Microbiol; 2022 Oct; 71(10):. PubMed ID: 36301611
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of eravacycline and mechanisms of resistance in enterococci.
    Boukthir S; Dejoies L; Zouari A; Collet A; Potrel S; Auger G; Cattoir V
    Int J Antimicrob Agents; 2020 Dec; 56(6):106215. PubMed ID: 33122095
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sun X; Zhang B; Xu G; Chen J; Shang Y; Lin Z; Yu Z; Zheng J; Bai B
    Ann Lab Med; 2021 May; 41(3):293-301. PubMed ID: 33303714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.
    Bax HI; de Vogel CP; Mouton JW; de Steenwinkel JEM
    J Antimicrob Chemother; 2019 Oct; 74(10):2930-2933. PubMed ID: 31236595
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Fujiwara K; Aono A; Asami T; Morimoto K; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Mitarai S
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0157922. PubMed ID: 37154742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates
    Nicklas DA; Maggioncalda EC; Story-Roller E; Eichelman B; Tabor C; Serio AW; Keepers TR; Chitra S; Lamichhane G
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0170421. PubMed ID: 34662184
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zeng W; Zhang X; Liu Y; Zhang Y; Xu M; Wang S; Sun Y; Zhou T; Chen L
    Front Microbiol; 2022; 13():1043736. PubMed ID: 36483205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant
    Lee YT; Chen HY; Yang YS; Chou YC; Chang TY; Hsu WJ; Lin IC; ; Sun JR
    Front Microbiol; 2020; 11():584789. PubMed ID: 33224122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antimicrobial activity of doxycycline, minocycline, and tigecycline against Mycobacterium abscessus complex: A meta-analysis study.
    Zhang W; Dong L; Men P; Jiang G; Wang F; Wang C; Cheng M; Huang H; Yu X
    Diagn Microbiol Infect Dis; 2024 Oct; 110(2):116435. PubMed ID: 39032320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase.
    Rudra P; Hurst-Hess K; Lappierre P; Ghosh P
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility testing of tetracycline-class antibiotics against slowly growing non-tuberculous mycobacteria.
    Li A; Tan Z; He S; Chu H
    Clin Exp Pharmacol Physiol; 2023 Jul; 50(7):604-609. PubMed ID: 37086075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease.
    Rimal B; Nicklas DA; Panthi CM; Lippincott CK; Belz DC; Ignatius EH; Deck DH; Serio AW; Lamichhane G
    mSphere; 2023 Apr; 8(2):e0066522. PubMed ID: 36912629
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China.
    Yang Y; Bian L; Hang X; Yan C; Huang Y; Ye F; Zhang G; Jin G; Bi H
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115129. PubMed ID: 32739761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antibacterial activities and resistance mechanisms of omadacycline and tigecycline against Enterococcus faecium.
    Liu X; Zhang C; Zhao Y; Cheng H; Wang Y; Wang Z; Shang Y; Zheng J; Yu Z; Shi Y
    J Antibiot (Tokyo); 2022 Aug; 75(8):463-471. PubMed ID: 35760902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.